MPR CME

CME/CE

CME/CE Courses


Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.


Featured Courses

Visualization of Chronic Rhinosinusitis: The Latest Developments in Diagnosis and Management On-Demand CME Interactive Infographic

Visualization of Chronic Rhinosinusitis: On-Demand CME Interactive Infographic | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
This interactive infographic activity will incorporate multiple interactive sections and multimedia formats to provide learners with practical in-depth views and demonstrations of the use of medications and procedures within the nasal anatomy for treating patients with CRS with and without NPs to help them evaluate these current and cutting-edge treatments and consider how to incorporate them into clinical practice.
Moderate to Deep Neuromuscular Blockade and Reversal

Moderate to Deep Neuromuscular Blockade and Reversal | myCME

AMA PRA Category 1 Credit(s)TM
In this 1.5-hour online educational activity, interprofessional faculty will use patient cases to discuss the clinical effects of neuromuscular blocking and reversal agents, including key components of NMB and reversal during the intraoperative phase of care and neuromuscular monitoring.
Targeted Treatments for Urothelial Cancer

Targeted Treatments for Urothelial Cancer

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), AANP Contact Hour(s)
This activity will help advanced practitioners who treat patients with UC to know how to select and sequence these treatments.
The Core Essentials of Immuno-Oncology Now and Into the Future: Pathophysiology, Mechanisms, Immunotherapy and irAEs – Mechanisms Underlying irAEs

The Core Essentials of Immuno-Oncology Now and Into the Future: Pathophysiology, Mechanisms, Immunotherapy and irAEs – Mechanisms Underlying irAEs | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
The purpose of this initiative is to provide oncology clinicians with a foundation of knowledge about the immune system, particularly the interplay between immune mechanisms and the tumor microenvironment, and how this interplay relates to the mechanisms of action (MOA) of existing immune checkpoint inhibitors, as well as those in development that target novel checkpoints.
Case study: Initiating AUD Treatment for a 49-Year-Old Woman Referred After an ED Visit

Case Study: Initiating AUD Treatment for a 49-Year-Old Woman Referred After an ED Visit | myCME

AMA PRA Category 1 Credit(s)TM, AAPA Category I CME credit, ANCC Contact Hour(s), CE for Pharmacists
Outpatient management for alcohol use disorder (AUD) can be a formidable challenge, especially in a patient who is resistant to treatment. Clinicians need to recognize multiple issues, including concerns about comorbidities and drug-drug interactions, when initiating treatment in patients recently referred from the emergency department.
Making the Case for Pharmacologic Treatment in Alcohol Use Disorder

Making the Case for Pharmacologic Treatment in Alcohol Use Disorder | myCME

AMA PRA Category 1 Credit(s)TM, AAPA Category I CME credit, ANCC Contact Hour(s), CE for Pharmacists
Alcohol use disorder (AUD) is a chronic disorder that occurs along a spectrum of mild, moderate, and severe disease. Three agents indicated for AUD, as well as several off-label medications, can help patients achieve better overall health outcomes by reducing their alcohol intake.

More

Advances in Sustained Delivery of Anti-VEGF Therapy: Prepare for Practice Change | myCME

AMA PRA Category 1 Credit(s)TM
Join Drs. Arshad M. Khanani and Carl D. Regillo, as they discuss current and emerging strategies for effective and durable treatment of neovascular retinal diseases. The expert faculty will present exciting new data to inform optimal use of currently available intravitreal antivascular endothelial growth factor (anti-VEGF) therapies, as well as the science and surgical techniques related to unprecedented new options for sustained delivery of anti-VEGF therapy that are coming soon.

Advances in Treatment in Risk Influenza Patients with Cardiometabolic Conditions | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
Given that patients with diabetes, heart disease, obesity, or other cardiometabolic risk factors are at a high-risk for developing flu-related complications, it is important for clinicians that care for these patients to be aware of the impact of influenza. This webinar, led by 3 experts in the field, will address the latest evidence in influenza treatment and management of patients with chronic cardiometabolic health conditions.

Advancements in Cancer Management 2020 Part II | myCME

AMA PRA Category 1 Credit(s)TM, AOA Category 1 Credit
This module is Part II in Advancements in Cancer Management, a recurring CME Forum for primary care providers.

Advanced Concepts in Navigation | myCME

CNE Contact Hour(s)
More and more of oncology patients present with multiple co-morbidities, challenges with health literacy and a lack of understanding of how social determinants of health can impact their cancer outcomes. The success of a program depends on its leadership, planning and implementation processes, and the oncology nurse navigators employed in the program.

Advanced Basal Cell Carcinoma: How to Navigate Challenging Clinical Scenarios with Systemic Treatment | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
Join Karl Lewis, MD, and Aleksandar Sekulic, MD, PhD, as they discuss the importance of the hedgehog pathway in the pathogenesis of BCC and the role of hedgehog inhibitors in advanced BCC.

Adopting a Tailored Approach to Managing Unmet Needs in Osteoarthritis | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
This CME Outfitters Snack focuses on recognizing the complex pathogenesis of OA, applying The Osteoarthritis Research Society International (OARSI) guidelines to non-surgical management, and evaluating emerging data in order to set realistic goals with patients and meet unmet needs in the management of OA.

Addressing the Real-World Challenge of HCV Cure in People Who Inject Drugs: Opportunities for Current and New HCV Treaters | myCME

AMA PRA Category 1 Credit(s)TM
In this activity, expert faculty will present the epidemiologic imperative for HCV treatment as prevention within populations of people who inject drugs (PWID). Potential barriers to treatment of HCV-positive PWID, including outdated clinical assumptions regarding treatment eligibility and prescribing limitations, will be discussed.

Addressing the Management of Progressive Multiple Sclerosis: Utilization of an Evidence-Based Approach | myCME

AMA PRA Category 1 Credit(s)TM
Multiple sclerosis (MS) is classically a chronic neurologic disease characterized by attacks of focal neurological deficits secondary to inflammatory, demyelinating plaque(s). A new chapter in the fight against MS starts; now more than ever there is a need to distinguish the subtypes of MS for appropriate evaluation and treatment.

Addressing Barriers to Insulin Initiation in Type 2 Diabetes | myCME

AMA PRA Category 1 Credit(s)TM, NCPD Contact Hour(s), CE for Pharmacists, AAFP Prescribed Credit, ABIM MOC Points
This activity informs providers how to better initiate individualized treatment for patients with type 2 diabetes that are hesitant to insulin initiation. Also reviewed are the most up-to-date insulin therapies and the current challenges and opportunities to improve diabetes care in diverse and underserved patient populations.

Addiction Medicine for Non-Specialists for NPs and PAs | myCME

AMA PRA Category 1 Credit(s)TM, AAFP Prescribed Credit
Special NP/PA price. Case-based look at the most relevant information on the identification and management of substance use disorders. 12.5 credits.

Adapting and Adjusting: Best Practices for Utilizing Telehealth in Osteoarthritis Management | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
The final installment in this CME Outfitters Snack series on managing OA focuses on best practices for utilizing telehealth, including encouraging patients to maximize mobility in time of isolation, increasing the utilization of video in telehealth and wearable tech, and the consideration of both operative and non-operative measures for treatment.

Addiction Medicine for Non-Specialists | myCME

AMA PRA Category 1 Credit(s)TM, AAFP Prescribed Credit
Case-based, comprehensive look at the most relevant information on the identification and management of substance use disorders. 12.5 credits.

Acute Migraine Headache With Comorbid Cardiovascular Disease | myCME

AMA PRA Category 1 Credit(s)TM, AAFP Prescribed Credit
Using a case study, 3 experts on treating headaches describe the management of migraines in a patient with comorbid cardiovascular disease. They review neuromodulation, lifestyle modifications, and recently approved medications.

Building a Framework for Best Practices in RA Management: ACR/EULAR Guidelines: Need for Earlier Appropriate Management of RA | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
An in-depth review of key clinical trials data on a treat-to-target strategy of care and of the distinguishing features of the new 2020 EULAR RA guidelines and proposed updates to the 2016 ACR RA guidelines.

AACE Advanced Technology for Diabetes Care | myCME

AMA PRA Category 1 Credit(s)TM, ABIM MOC Credit, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
Two video-based, pre-recorded webinars with presenters who are experts in the field will cover the following topics: Exploring CGM, Identifying Patients Who Will Benefit from CGM , and Emerging Technologies: A Better Life for Patients with Diabetes

Updates for Your PAD Patients Post-Revascularization | myCME

AMA PRA Category 1 Credit(s)TM
In this activity, expert faculty cover the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. The purpose of this activity is to provide learners with an engaging presentation to help them optimize anticoagulant therapy in their patients with PAD post-revascularization.

A Migraine Toolbox—Module 1: Diagnosis | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CDE Credit, CE for Pharmacists
This module shares a methodology, including questionnaires, that will allow you to recognize migraine disease in its many presentations – all within the tight constraints of your busy medical setting.